TITLE

Progress in the Introduction of Rotavirus Vaccine -- Latin America and the Caribbean, 2006-2010

PUB. DATE
December 2011
SOURCE
MMWR: Morbidity & Mortality Weekly Report;12/2/2011, Vol. 60 Issue 47, p1611
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the progress in the introduction of rotavirus vaccine in the Caribbean and Latin America from 2006 to 2010. It says that one of the leading causes of childhood mortality and morbidity related to diarrhea in the regions is rotavirus disease. According to the author, national immunization schedules in various countries including El Salvador, Mexico and Brazil, started in January 2011.
ACCESSION #
67712272

 

Related Articles

  • Low Prevalence of Rotavirus and High Prevalence of Norovirus in Hospital and Community Wastewater after Introduction of Rotavirus Vaccine in Nicaragua. Bucardo, Filemón; Lindgren, Per-Eric; Svensson, Lennart; Nordgren, Johan // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Rotavirus (RV) and norovirus (NoV) are major causes of pediatric diarrhea and are altogether associated with approximately 800,000 deaths in young children every year. In Nicaragua, national RV vaccination program using the pentavalent RV5 vaccine from Merck was implemented in October 2006. To...

  • New rotavirus vaccine for diarrhoea reaches Rwanda.  // Africa Health;Jul2012, Vol. 34 Issue 5, p11 

    The article reports that Rwanda is the latest among the growing number of African countries to receive the rotavirus vaccine for children against diarrhea.

  • Childhood Diarrhea Deaths after Rotavirus Vaccination in Mexico. Richardson, Vesta; Parashar, Umesh; Patel, Manish // New England Journal of Medicine;8/25/2011, Vol. 365 Issue 8, p772 

    A letter to the editor is presented about the reduction in diarrhea-related deaths in children after the introduction of rotavirus vaccination in Mexico.

  • Free rotavirus vaccine will be a one-week rush for some. Castaneda, Reynald // New Zealand Doctor;4/23/2014, p5 

    The article reports on the changes in the immunization schedule wherein the rotavirus vaccine RotaTeq (MSD) will be made available free for infants under 15 weeks in New Zealand beginning July 1, 2014.

  • Full, partial immunization with rotavirus vaccine highly protective.  // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p42 

    The article discusses research on the effectiveness of full or partial immunization with pentavalent rotavirus vaccine, by Mary Allen Staat and colleagues, published in "Pediatrics."

  • Rotavirus morbidity and mortality in children in Brazil. Sartori, Ana Marli Christovam; Valentim, Joice; de Soárez, Patricia Coelho; Novaes, Hillegonda Maria Dutilh // Revista Panamericana de Salud Publica;Feb2008, Vol. 23 Issue 2, p92 

    Objective To study the epidemiology of rotavirus and estimate rotavirus-associated morbidity and mortality in children ≤ 5 years of age in Brazil in 2004 before introducing the rotavirus vaccine in Brazil's National Immunization Program (Programa Nacional de Imunizações, PNI)....

  • WHO Endorses Rotavirus Vaccine. HOULTON, SARAH // Pharmaceutical Executive;Jul2009, Vol. 29 Issue 7, p18 

    The article reports that the World Health Organization (WHO) has ruled that rotavirus vaccination be included in all infant immunization programs. The ruling came after a new research, according to which the vaccines are effective in countries where child mortality is high. WHO has estimated...

  • Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico. Richardson, Vesta; Hernandez-Pichardo, Joselito; Quintanar-Solares, Manjari; Esparza-Aguilar, Marcelino; Johnson, Brian; Gomez-Altamirano, Cesar Misael; Parashar, Umesh; Patel, Manish // New England Journal of Medicine;1/28/2010, Vol. 362 Issue 4, p299 

    Background: A phased introduction of a monovalent rotavirus vaccine occurred in Mexico from February 2006 through May 2007. We assessed the effect of vaccination on deaths from diarrhea in Mexican children in 2008 and 2009. Methods: We obtained data on deaths from diarrhea, regardless of cause,...

  • Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice. Hao Feng; Xin Li; Weibin Song; Mei Duan; Hong Chen; Tao Wang; Jiangli Dong // Frontiers in Plant Science;5/31/2017, p1 

    Rotavirus is the leading cause of severe diarrheal disease among newborns. Plantbased rotavirus vaccines have been developed in recent years and have been proven to be effective in animal models. In the present study, we report a bivalent vaccine candidate expressing rotavirus subunits VP6 and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics